Date Range
toReport Types
Condition
See all (23)
Region of the Body
See all (15)
Specialties
See all (15)
Emerging Treatments
OE Recommends Topics
Multimedia
Journal
Conference Series
Evidence Series
Lower incidence of vertebral fracture with romosozumab vs placebo for osteoporosis
N Engl J Med. 2016 Oct 20;375(16):1532-1543
Romosozumab versus placebo, alendronate, and teriparatide for postmenopausal osteoporosis
Climacteric. 2018 Apr;21(2):189-195
Intra-articular or sub cutaneous vacuum drainage for Total Knee Arthroplasty?
Clin Orthop Relat Res. 2010 Aug;468(8):2168-76. Epub 2010 Feb 2
Romosozumab has no impact on radiographic or clinical outcomes following hip fracture ORIF
J Bone Joint Surg Am. 2020 ;():. 10.2106/JBJS.19.00790
Decompression Versus Transposition for Cubital Tunnel Syndrome
J Hand Surg Am. 2008 Oct;33(8):1314.e1-12.
SC and IM-delivered diclofenac vs Voltaren for pain following minor surgery
Pain Pract. 2015 Jan;15(1):31-9.
Oral edoxaban vs. subcutaneous enoxaprain for VTE prophylaxis after TKA
Thromb Res. 2014 Dec;134(6):1198-204
Subcutaneous Teriparatide for Pelvic Fracture Healing: A Phase 2 Randomized Controlled Trial
. 2022 01-Jan;():. 10.1007/s00198-021-06065-4
IORA prophylaxis achieves greater vancomycin tissue concentration vs IV administration in TKA
J Arthroplasty. 2018 Jul;33(7S):S13-S18. doi: 10.1016/j.arth.2018.03.013
No significant difference for improvement of erosive hand OA pain between adalimumab and placebo
Osteoarthritis Cartilage. 2018 Jul;26(7):880-887. doi: 10.1016/j.joca.2018.02.899
Denosumab reduces risk of fractures in post-menopausal women
N Engl J Med. 2009 Aug 20;361(8):756-65. Epub 2009 Aug 11.
Greater BMD increase with denosumab vs ZOL in patients switching from oral bisphosponates
J Clin Endocrinol Metab. 2016 Aug;101(8):3163-70
Enoxaparin thromboprophylaxis effective after hip replacement
J Bone Joint Surg Am. 2001 Mar;83-A(3):336-45